These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29475730)

  • 1. Evaluation of the use of various rat strains for immunogenic potency tests of Sabin-derived inactivated polio vaccines.
    Someya Y; Ami Y; Takai-Todaka R; Fujimoto A; Haga K; Murakami K; Fujii Y; Shirato H; Oka T; Shimoike T; Katayama K; Wakita T
    Biologicals; 2018 Mar; 52():12-17. PubMed ID: 29475730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national reference for inactivated polio vaccine derived from Sabin strains in Japan.
    Shirato H; Someya Y; Ochiai M; Horiuchi Y; Takahashi M; Takeda N; Wakabayashi K; Ouchi Y; Ota Y; Tano Y; Abe S; Yamazaki S; Wakita T;
    Vaccine; 2014 Sep; 32(40):5163-9. PubMed ID: 25090648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
    Crawt L; Atkinson E; Tedcastle A; Pegg E; ; Minor P; Cooper G; Rigsby P; Martin J
    J Infect Dis; 2020 Feb; 221(4):544-552. PubMed ID: 30788503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the thermal denaturation of Sabin-derived inactivated polio vaccines on the D-antigenicity and the immunogenicity in rats.
    Murakami K; Fujii Y; Someya Y
    Vaccine; 2020 Apr; 38(17):3295-3299. PubMed ID: 32197923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV).
    Li Z; Ding W; Guo Q; Liu Z; Zhu Z; Song S; Li W; Liao G
    Hum Vaccin Immunother; 2018; 14(8):1987-1994. PubMed ID: 29601259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.
    Bockstal V; Tiemessen MM; Achterberg R; Van Wordragen C; Knaapen AM; Serroyen J; Marissen WE; Schuitemaker H; Zahn R
    Vaccine; 2018 Nov; 36(46):6979-6987. PubMed ID: 30314910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunogenicity of sabin inactivated poliovirus vaccine induced by diphtheria-tetanus-acellular pertussis and Sabin inactivated poliovirus combined vaccine].
    Ma Y; Qin M; Hu HQ; Ji G; Feng L; Gao N; Gu J; Xie BF; He JH; Sun MB
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):197-200. PubMed ID: 21977591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Immunogenicity of a New Inactivated Polio Vaccine Made From Sabin Strains: A Randomized, Double-Blind, Active-Controlled, Phase 2/3 Seamless Study.
    Capeding MR; Gomez-Go GD; Oberdorfer P; Borja-Tabora C; Bravo L; Carlos J; Tangsathapornpong A; Uppala R; Laoprasopwattana K; Yang Y; Han S; Wittawatmongkol O
    J Infect Dis; 2022 Aug; 226(2):308-318. PubMed ID: 33351072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing.
    Deng Y; Cai W; Li J; Li Y; Yang X; Ma Y; Yao Y; Yang L; Shi L; Sun M
    Vaccine; 2019 Jan; 37(1):130-136. PubMed ID: 30467062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of fractional-dose of inactivated poliomyelitis vaccine made from Sabin strains delivered by intradermal vaccination in Wistar rats.
    Ma Y; Ying Z; Li J; Gu Q; Wang X; Cai L; Shi L; Sun M
    Biologicals; 2022 Jan; 75():3-11. PubMed ID: 35058137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines.
    Kouiavskaia D; Puligedda RD; Dessain SK; Chumakov K
    J Virol Methods; 2020 Feb; 276():113785. PubMed ID: 31765719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzed immunogenicity of fractional doses of Sabin-inactivated poliovirus vaccine (sIPV) with intradermal delivery in rats.
    Ma L; Cai W; Sun M; Cun Y; Zhou J; Liu J; Hu W; Zhang X; Song S; Jiang S; Liao G
    Hum Vaccin Immunother; 2016 Dec; 12(12):3125-3131. PubMed ID: 27558963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency of the Sabin inactivated poliovirus vaccine (sIPV) after exposure to freezing temperatures in cold chains.
    Cai W; Ping L; Shen W; Liu J; Zhang M; Zhou J; Peng J; Wang M; Zhu Y; Ji G; Wang X; Ji Q; Lai C; Shi L; Che Y; Sun M
    Hum Vaccin Immunother; 2020 Aug; 16(8):1866-1874. PubMed ID: 32118517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine.
    Sun M; Ma Y; Xu Y; Yang H; Shi L; Che Y; Liao G; Jiang S; Zhang S; Li Q
    Vaccine; 2014 Feb; 32(9):1100-6. PubMed ID: 24412578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of formulation on spray dried Sabin inactivated polio vaccine.
    Kanojia G; Ten Have R; Brugmans D; Soema PC; Frijlink HW; Amorij JP; Kersten G
    Eur J Pharm Biopharm; 2018 Aug; 129():21-29. PubMed ID: 29787800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses of Macaca fascicularis against a new inactivated polio vaccine derived from Sabin strains (sIPV) in DTaP-sIPV vaccine.
    Sato Y; Shiosaki K; Goto Y; Sonoda K; Kino Y
    Biologicals; 2013 May; 41(3):184-9. PubMed ID: 23375165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sIPV process development for costs reduction.
    Thomassen YE; Bakker WA
    Vaccine; 2015 Aug; 33(35):4307-12. PubMed ID: 25858858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.